Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - NAVIDEA BIOPHARMACEUTICALS, INC. | Financial_Report.xls |
| 10-K - FORM 10-K - NAVIDEA BIOPHARMACEUTICALS, INC. | v303459_10k.htm |
| EX-3.1 - EXHIBIT 3.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | v303459_ex3-1.htm |
| EX-32.1 - EXHIBIT 32.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | v303459_ex32-1.htm |
| EX-23.1 - EXHIBIT 23.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | v303459_ex23-1.htm |
| EX-31.1 - EXHIBIT 31.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | v303459_ex31-1.htm |
| EX-21.1 - EXHIBIT 21.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | v303459_ex21-1.htm |
| EX-32.2 - EXHIBIT 32.2 - NAVIDEA BIOPHARMACEUTICALS, INC. | v303459_ex32-2.htm |
| EX-24.1 - EXHIBIT 24.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | v303459_ex24-1.htm |
| EX-31.2 - EXHIBIT 31.2 - NAVIDEA BIOPHARMACEUTICALS, INC. | v303459_ex31-2.htm |
Exhibit 10.5
SCHEDULE IDENTIFYING MATERIAL DIFFERENCES BETWEEN
EMPLOYMENT AGREEMENTS
BETWEEN NAVIDEA BIOPHARMACEUTICALS, INC. AND
THE INDIVIDUALS LISTED BELOW
| Commencement Date | Termination Date | 2012 Base Salary | Amount of Severance | Amount of Severance upon Change in Control | ||||||||||||||||
| Mark J. Pykett | 4/15/2011 | 10/15/2012 | $ | 425,000 | $ | 468,750 | $ | 937,500 | ||||||||||||
| Thomas H. Tulip | 6/1/2011 | 5/31/2012 | $ | 300,000 | $ | 225,000 | $ | 450,000 | ||||||||||||
| Frederick O. Cope | 1/1/2011 | 12/31/2012 | $ | 271,000 | $ | 245,000 | $ | 367,500 | ||||||||||||
| Brent L. Larson | 1/1/2011 | 12/31/2012 | $ | 265,000 | $ | 207,000 | $ | 310,500 | ||||||||||||
| Rodger A. Brown | 1/1/2011 | 12/31/2012 | $ | 191,000 | $ | 165,000 | $ | 247,500 | ||||||||||||